☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
approvalMHLW
Regeneron's Ronapreve Antibody Cocktail (casirivimab and imdevimab) Receives MHLW's Approval for the Treatment of Mild to Moderate...
July 20, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.